| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/16/2001 | CA2036977C Imidazopyridazines, their production and use |
| 10/16/2001 | CA2035967C Oxetanones |
| 10/16/2001 | CA2028528C Hydrogel wound dressing product |
| 10/16/2001 | CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase |
| 10/16/2001 | CA2015470C Fluorinated arachidonic acid derivatives |
| 10/13/2001 | CA2344182A1 Therapeutic agent for dermatitis |
| 10/13/2001 | CA2344089A1 Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues |
| 10/13/2001 | CA2343850A1 Synergistic effect of a sulfonylurea and/or non-sulfonylurea k+ atp channel blocker, and a phosphodiesterase 3 type inhibitor |
| 10/12/2001 | CA2318665A1 Method of treating onychomycosis |
| 10/11/2001 | WO2001075454A2 Diagnosis and treatment of alzheimer's disease |
| 10/11/2001 | WO2001075170A1 A functional assay of high-density lipoprotein |
| 10/11/2001 | WO2001075168A1 Control of a gene induced by oxidized lipids in human artery wall cells |
| 10/11/2001 | WO2001075164A2 Rna sequence-specific mediators of rna interference |
| 10/11/2001 | WO2001075135A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 10/11/2001 | WO2001075108A1 Human ion channel protein and polynucleotides encoding the same |
| 10/11/2001 | WO2001075081A1 Methods for identifying compounds useful for inhibiting geranylgeranyl diphosphate synthase |
| 10/11/2001 | WO2001075078A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 10/11/2001 | WO2001074983A1 Foamable antimicrobial formulation |
| 10/11/2001 | WO2001074900A2 Nuclear factor kb inducing factor |
| 10/11/2001 | WO2001074898A2 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 10/11/2001 | WO2001074859A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 10/11/2001 | WO2001074856A2 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 10/11/2001 | WO2001074841A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 10/11/2001 | WO2001074840A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 10/11/2001 | WO2001074839A2 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 10/11/2001 | WO2001074835A1 O-glucosylated benzamide sglt2 inhibitors and method |
| 10/11/2001 | WO2001074834A1 O-aryl glucoside sglt2 inhibitors and method |
| 10/11/2001 | WO2001074827A1 Phosphoramidate prodrugs |
| 10/11/2001 | WO2001074820A1 Novel derivatives and analogues of galanthamin |
| 10/11/2001 | WO2001074819A1 Analgesics containing morphinan n-oxide derivatives as the active ingredient |
| 10/11/2001 | WO2001074817A1 Hydrazide derivatives |
| 10/11/2001 | WO2001074816A1 4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides as antiviral agents |
| 10/11/2001 | WO2001074815A2 Phenyl-substituted imidazopyridines |
| 10/11/2001 | WO2001074814A1 Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands |
| 10/11/2001 | WO2001074813A2 METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS |
| 10/11/2001 | WO2001074812A1 Novel benzosultam oxazolidinone antibacterial agents |
| 10/11/2001 | WO2001074810A2 Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists |
| 10/11/2001 | WO2001074809A1 Acylthiophene derivatives and use thereof as drugs |
| 10/11/2001 | WO2001074808A1 Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides |
| 10/11/2001 | WO2001074807A1 Indolylpyrrole derivatives and cell death inhibitors |
| 10/11/2001 | WO2001074806A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 10/11/2001 | WO2001074805A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 10/11/2001 | WO2001074804A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain |
| 10/11/2001 | WO2001074797A1 Phenylsulphonylpiperazinyl derivatives as 5-ht receptor ligands |
| 10/11/2001 | WO2001074796A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 10/11/2001 | WO2001074791A1 Diazepane derivatives or salts thereof |
| 10/11/2001 | WO2001074790A2 Novel compounds for enhancing chemotherapy |
| 10/11/2001 | WO2001074788A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 10/11/2001 | WO2001074787A2 Crystalline pharmaceutical |
| 10/11/2001 | WO2001074784A1 CYCLIC LACTAMS AS INHIBITORS OF A-β PROTEIN PRODUCTION |
| 10/11/2001 | WO2001074783A1 Cyclic lactams as inhibitors of a βετα protein production |
| 10/11/2001 | WO2001074780A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 10/11/2001 | WO2001074779A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers |
| 10/11/2001 | WO2001074778A1 (1-adamantylamino)pyridines and method of their preparation |
| 10/11/2001 | WO2001074775A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 10/11/2001 | WO2001074773A2 Phenyl-substituted indoles as histamine h3-receptor antagonists |
| 10/11/2001 | WO2001074772A1 Chemokine receptor antagonists |
| 10/11/2001 | WO2001074771A1 Pyrrole-2,5-dione derivatives for the treatment of diabetes |
| 10/11/2001 | WO2001074769A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 10/11/2001 | WO2001074768A2 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 10/11/2001 | WO2001074765A1 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds |
| 10/11/2001 | WO2001074763A1 Aryl and heteroaryl sulfonates |
| 10/11/2001 | WO2001074761A1 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 10/11/2001 | WO2001074759A1 Treatment of tumors with rar alpha selective retinoid compounds in combination with other anti-tumor agents |
| 10/11/2001 | WO2001074506A1 Extrusion die |
| 10/11/2001 | WO2001074432A1 Microencapsulated fragrances and methods of coating microcapsules |
| 10/11/2001 | WO2001074404A2 Compositions containing genetically modified lung cancer cells expressing a tgf-beta inhibitor |
| 10/11/2001 | WO2001074402A2 Camptothecin conjugates |
| 10/11/2001 | WO2001074401A2 Camptothecin complexes |
| 10/11/2001 | WO2001074396A1 Composition and method for promoting oral health |
| 10/11/2001 | WO2001074395A2 Amiodarone-containing parenteral solution |
| 10/11/2001 | WO2001074394A1 New combination of a betablocker and a cholesterol-lowering agent |
| 10/11/2001 | WO2001074391A1 Preventives/remedies for kidney diseases |
| 10/11/2001 | WO2001074390A2 The use of a calcium channel blocker for treating renal disorders |
| 10/11/2001 | WO2001074389A2 Improved treatment of neovascularization |
| 10/11/2001 | WO2001074388A1 Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma |
| 10/11/2001 | WO2001074370A1 Use of feracryl for the treatment of peptic/duodenal ulcer and/or cholera |
| 10/11/2001 | WO2001074369A1 Divided dose therapies with vascular damaging activity |
| 10/11/2001 | WO2001074368A1 Combination therapies with vascular damaging activity |
| 10/11/2001 | WO2001074367A1 Pharmaceutical composition based on a non-steroid anti-inflammatory agent |
| 10/11/2001 | WO2001074366A1 Use of fulvestrant in the treatment of resistant breast cancer |
| 10/11/2001 | WO2001074365A2 An efficacious dosage regimen of galantamine that reduces side effects |
| 10/11/2001 | WO2001074364A2 A use of galantamine for the treatment of alzheimer's disease; targeting the underlying cause of the disease |
| 10/11/2001 | WO2001074363A1 Pharmaceutical composition containing 3-[4[2-phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxy propanoicacid |
| 10/11/2001 | WO2001074362A1 Inhibition of cyclooxygenase-2 activity |
| 10/11/2001 | WO2001074361A1 Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract |
| 10/11/2001 | WO2001074360A1 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 10/11/2001 | WO2001074359A1 Sigma receptor ligands and their medical uses |
| 10/11/2001 | WO2001074358A1 Methods for treating sexual dysfunction with apomorphine at specified plasma concentration levels |
| 10/11/2001 | WO2001074357A1 Hydrophilic molecular disperse solutions of carvedilol |
| 10/11/2001 | WO2001074356A1 Concentrated solutions of carvedilol |
| 10/11/2001 | WO2001074355A1 Method for treating cells resistant to antineoplastic agents |
| 10/11/2001 | WO2001074353A1 A synergistic anti-malarial formulation |
| 10/11/2001 | WO2001074352A1 Compositions for promoting sleep |
| 10/11/2001 | WO2001074351A1 Composition for the prevention and/or treatment, in newborn babies, of the effects of complications during childbirth |
| 10/11/2001 | WO2001074350A1 Nasal administration of agents for the treatment of gastroparesis |
| 10/11/2001 | WO2001074349A1 Butylnitrone containing compositons for inhibition of cancer development |
| 10/11/2001 | WO2001074348A2 Vasopeptidase inhibitors to treat isolated systolic hypertension |
| 10/11/2001 | WO2001074347A2 Method for reducing adverse effects of a weight loss regimen |
| 10/11/2001 | WO2001074346A2 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |